CX3CL1 and Parkinson disease: Indeed, some authors found that using different isoforms of CX3CL1 in a gene therapy was effective to reduce neuron loss in a rat Parkinson’s disease model, suggesting a positive role of soluble CX3CL1 in neuroprotection [77].